NDC 71225-138 - MERZEE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71225-138
- Manufacturer
- Lupin Pharmaceuticals, Inc. | Slayback Pharma LLC | NextPharma Ploermel
- Effective date
- 2024-03-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MERZEE - Lupin Pharmaceuticals, Inc. | Slayback Pharma LLC | NextPharma Ploermel | Lupin Pharmaceuticals, Inc. | Slayback Pharma LLC | NextPharma Ploermel | 2024-03-05 | Human Prescription Drug Label |
| MERZEE - Slayback Pharma LLC | Capsugel Ploermel SAS | Slayback Pharma LLC | Capsugel Ploermel SAS | 2022-06-30 | Human Prescription Drug Label |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.